CCL: Announcing Release of DivCon Discovery Suite 5.1.1



 Sent to CCL by: "Lance M Westerhoff" [lance###quantumbioinc.com]
 Dear Colleague,
 We are proud to announce the release of version 5.1.1 of our linear scaling,
 semi-empirical, quantum
 mechanics solution for structure-based drug discovery. This release of the
 DivCon Discovery Suite
 further refines our integration with the Molecular Operating Environment (MOE)
 platform, and we have
 addressed a number of key requests made by our users in the field. For a full
 rundown of the new
 features of the Suite, please visit the following link:
 http://www.quantumbioinc.com/news/show/Release-5.1.1
 Thank you for your time, and certainly feel free to contact me if you have any
 questions.
 -Lance
 ____________________
 Lance M. Westerhoff, Ph.D.
 General Manager
 QuantumBio Inc.
 WWW:    http://www.quantumbioinc.com
 Email:    lance\a/quantumbioinc.com
 Phone:   814-235-6908
 Fax:        814-235-6909